BCLC group, Liver Unit. Hospital Clínic of Barcelona. #ILCA GB Advisor
Barcellona, Spagna
Joined February 2019
- Tweets818
- Following458
- Followers736
- Likes5.2K
Marco Sanduzzi Zamparelli retweeted
Active involvement of our radiologists @MaarioMatute and @JordiRimola in the @sediabdomen meeting. Imaging plays a pivotal role in liver cancer management within the MTB. Interaction with all key areas of knowledge primes their major clinical insight @hospitalclinic @idibaps
Marco Sanduzzi Zamparelli retweeted
Here you have the link to join the action and enjoy interaction while macimizing the acquisition of knowledge.
update.bclc.cat/bclc2026/en/…
Marco Sanduzzi Zamparelli retweeted
1st International activity of the Liver Cancer Chair of the @UniBarcelona takes place in Naples. Sharing experience and knowledge. An optimal way to celebrate the #livercancerawarenessmonth @hospitalclinic @idibaps
Marco Sanduzzi Zamparelli retweeted
👨🏫 Ya está abierto el plazo para solicitar la inscripción a la 5ª edición del cuso propio «Formación Integral en Cáncer Hepático» de la #AEEH. Dirigen los doctores @anamatillapena y @MarcoSanduzzi-Zamparelli.
💻 Las plazas son limitadas por lo que si cumples los requisitos generales no lo dudes y solicita tu inscripción a través del formulario online.
⌛ El plazo de solicitud de inscripción finaliza el 19 de octubre a las 23:59 hrs. ¡Os animamos a inscribiros en esta formación única! 👇
aeeh.es/abierto-el-plazo-par…
Marco Sanduzzi Zamparelli retweeted
October is Liver Cancer Awareness Month 🎗️
We stand with the ILCA Advocacy Committee & global experts to elevate care, share vital insights, and bridge gaps in policy, prevention, and patient support.
Learn more on how to join us: ilcalive.org/wp-content/uplo…
Marco Sanduzzi Zamparelli retweeted
Two months to go! A very promising event with international KOLs to debate all the information released in the last 12 months. Program at
docs.academia.cat/mailing/16…
Registration at inscripcions.academia.cat/fo…
@hospitalclinic @idibaps @AEEHLiver @ContraCancerEs @ILCAnews
Marco Sanduzzi Zamparelli retweeted
Was not easy to find the time slot to take the picture of the BCLC members attending @ILCAnews: @ma5RN @martafortuny10 @nllarch @MarcoSanduzzi & @bruixj Happiness at work is a privilege! What else! @hospitalclinic @idibaps
Marco Sanduzzi Zamparelli retweeted
What a fun week at #EASL2026 in Barcelona! Great hanging up with the editorial team from @JHepatology and enjoying the outstanding MASLD-HCC session with my good friends @CancerInflam, @derekamann1 and @MarcoSanduzzi Also proud to support my PhD student's poster! – at Hospitalet de Llobregat, Spain
Marco Sanduzzi Zamparelli retweeted
Early Sat am ☕️ at #EASL2026, but definitely worth waking up for exciting new data and discussions 💡 on “#MASLD-related #HCC: Pathogenesis, Immunology and Treatment” chaired by @CancerInflam and @MarcoSanduzzi
See you there!
@derekamann1 @EASLnews
pag.virtual-meeting.org/easl… – at Batu Ampar, Indonesia
Marco Sanduzzi Zamparelli retweeted
Trial design is an evolving issue in which statisticians should be involved from time zero. Expert knowledge in all dimensions is key
💬 Perspective: Bayesian methodology supports efficient, flexible clinical trial designs; FDA guidance encourages prespecification and sensitivity analysis of priors.
@f2harrell @d_spiegel
ja.ma/47hHTyb
Marco Sanduzzi Zamparelli retweeted
The next Talk Liver to Me podcast drops tomorrow!! Here's a sneak-peek from this interactive discussion between @MattiasMandorf1, @MarcoSanduzzi and @LorenzaRimassa!
Read more: easl.eu/event/updated-bclc-g…
#LiverTwitter #LiverX
Marco Sanduzzi Zamparelli retweeted
Present at #ILCA26 & share your latest research, receive feedback, spark new collaborations and most importantly contribute to the advancement of liver cancer care and research.
➡️Get started and submit before 13 April 2026: shorturl.at/eDxXr
@QingheZeng @Valeriechew29
Marco Sanduzzi Zamparelli retweeted
The call for abstracts is officially open for the ILCA Annual Conference and this is your moment to be where the science meets clinical practice.
Read more about the topics and submit your abstract before 13 April 2026: shorturl.at/fOtLI
@docamitgs
Marco Sanduzzi Zamparelli retweeted
Results of the GOING investigator initiated trial for 2nd line in HCC are already on-line. We tested a sequential add-on strategy rather than two drugs from star. Encouraging response rate while preserving safety. pubmed.ncbi.nlm.nih.gov/4172…
@hospitalclinic @idibaps @ContraCancerEs
Marco Sanduzzi Zamparelli retweeted
Here the link to the BCLC 2025 model authors.elsevier.com/c/1mZTW…. The CUSE approach informs options to consider according to strength of evidence. Individualized decision making with patient involvement. @hospitalclinic @ILCAnews @ContraCancerEs @EASLnews
Marco Sanduzzi Zamparelli retweeted
Great informative talk by @MarcoSanduzzi about future prospects of systemic treatment for HCC at the @AEEHLiver PGC. Experience + knowledge @hospitalclinic @idibaps @ContraCancerEs
Marco Sanduzzi Zamparelli retweeted
If you haven't heard yet, the ILCA Annual Conference is coming back to Europe this year and we’ll meet in Brussels, 3-5 Sept. !
Keep an eye out for more updates and the #ILCA26 abstract submission opening soon.
shorturl.at/FtDeV
For now, let’s look back at #ILCA25 📸
Marco Sanduzzi Zamparelli retweeted
It’s official – #ILCA26 is returning to Europe!
Join us in Brussels, Belgium, on 3–5 September 2026 for three days of insights into the latest in #livercancer research.
@StephenLChan1 @docamitgs @Valeriechew29 @LorenzaRimassa @AnjanaPillaiMD @siadaniela @allaire_manon
Marco Sanduzzi Zamparelli retweeted
A webinar to comment the Lancet Commission paper about liver cancer takes place on Thursday. We will comment geographic differences to be solved in order to secure access to effective treatments, as well as research challenges to be tackled .
link hubs.li/Q03GK-R30
